Samsung Bioepis logo

Samsung Bioepis Employee Directory

Pharmaceutical Manufacturing인천광역시, South Korea1001-5000 Employees

Samsung Bioepis is a biopharmaceutical company in the pharmaceutical manufacturing industry established in 2012 and based in Yeonsu District, Incheon, South Korea (postal code 21987). It develops and commercializes biosimilars and maintains a broad pipeline across immunology, oncology, ophthalmology, hematology, nephrology, and endocrinology. The company engages in global partnerships and market activity in Europe and Japan, including the May 2026 launch of OPUVIZ aflibercept 40 mg/mL vial in Europe and the May 2026 launch of Ustekinumab BS 45 mg syringe for subcutaneous injection in Japan through Nipro. Samsung Bioepis has pursued open-innovation and strategic collaborations, such as a 2025–2026 partnership with Nipro for development and commercialization of multiple biosimilar candidates in Japan, and an MoU with ATLATL Innovation Center to accelerate early-stage biotech innovation in the Asia-Pacific region. The company employs between 1,001 and 5,000 people and maintains its online presence at www.samsungbioepis.com.

Find Samsung Bioepis employees' phone numbers or email addresses

Samsung Bioepis Global Highlights

Location
Employees

North America
36

Minus sign iconPlus sign icon
  • United States Of America
    34
  • Canada
    2

Europe
32

Minus sign iconPlus sign icon
  • Netherlands
    19
  • Spain
    3
  • Italy
    3
  • United Kingdom Of Great Britain And Northern Ireland
    2
  • Sweden
    2
  • Germany
    2
  • Denmark
    1

Asia
3

Minus sign iconPlus sign icon
  • Bangladesh
    1
  • India
    1
  • Singapore
    1

South America
2

Minus sign iconPlus sign icon
  • Brazil
    2

Samsung Bioepis's Leadership

  • Vice President Clinical Research at Samsung Bioepis
    I. H.
    Vice President Clinical Research
  • Vice President (legal) at Samsung Bioepis
    S. S.
    Vice President (legal)
  • Vp Of Drug Product at Samsung Bioepis
    Y. K.
    Vp Of Drug Product
  • President & Chief Executive Officer at Samsung Bioepis
    K. K.
    President & Chief Executive Officer
  • Head Of Europe at Samsung Bioepis
    A. R.
    Head Of Europe
  • Digital Transformation Lead/Cio at Samsung Bioepis
    K. L.
    Digital Transformation Lead/Cio
  • Executive Vice President at Samsung Bioepis
    P. H.
    Executive Vice President
  • Vp, Head Of Ai at Samsung Bioepis
    D. K.
    Vp, Head Of Ai

Samsung Bioepis Employee Metrics

100%
50%
0%
2026
2025
  • Research
  • Program & Project Management
  • Operations
  • Engineering
  • Legal
  • Other
  • Manufacturing
  • Biotechnology
  • Administrative
  • Business
  • Quality Assurance

Contact profiles from Samsung Bioepis

Name
Title
Contact
Location
Last Update
  • Digital Transformation Lead/Cio at Samsung Bioepis
    K. L.
    Digital Transformation Lead/Cio
    South Korea
    Jun 01, 2026
  • President & Chief Executive Officer at Samsung Bioepis
    K. K.
    President & Chief Executive Officer
    South Korea
    Aug 11, 2026
  • Head Of Europe at Samsung Bioepis
    A. R.
    Head Of Europe
    Italy, Tuscany
    Jun 24, 2026
  • Executive Vice President at Samsung Bioepis
    P. H.
    Executive Vice President
    South Korea
    Sep 05, 2026
  • Vp, Head Of Ai at Samsung Bioepis
    D. K.
    Vp, Head Of Ai
    South Korea
    Jun 08, 2026
  • Vice President, Enable Team at Samsung Bioepis
    J. K. L.
    Vice President, Enable Team
    Bay
    Sep 01, 2026
  • Vice President, Device And Packaging Team at Samsung Bioepis
    S. C.
    Vice President, Device And Packaging Team
    South Korea, Incheon
    Sep 04, 2026
  • Vp, Clinical Research at Samsung Bioepis
    K. L.
    Vp, Clinical Research
    Jun 24, 2026
  • Vice President Clinical Research at Samsung Bioepis
    I. H.
    Vice President Clinical Research
    South Korea, Seoul
    May 05, 2026
  • Director Global Business Development - Head Of Biosimilars Business Development at Samsung Bioepis
    J. H.
    Director Global Business Development - Head Of Biosimilars Business Development
    May 05, 2026

Frequently Asked Questions

What is Samsung Bioepis known for?

Minus sign iconPlus sign icon
Samsung Bioepis was founded in 2012 and operates in the Pharmaceutical Manufacturing industry. Explore Samsung Bioepis's company overview page for more information.

What is Samsung Bioepis's most common email format?

Minus sign iconPlus sign icon
Samsung Bioepis employees' email format typically follows the pattern of First.Last@samsung.com. Trying to find reliable and up-to-date employee contact data? Find more Samsung Bioepis email formats with LeadIQ.

How many employees does Samsung Bioepis have currently?

Minus sign iconPlus sign icon
Samsung Bioepis has approximately 1.6K employees as of August 2026. These team members are located across 4 continents, including North America, Europe and Asia.

Who are Samsung Bioepis's key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, Samsung Bioepis's key employees include:

  • Vice President Clinical Research: I. H.
  • Vice President (legal): S. S.
  • Vp Of Drug Product: Y. K.
  • President & Chief Executive Officer: K. K.
  • Head Of Europe: A. R.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.